Recent Quotes
My Watchlist
Indicators
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Tempus AI, Inc. - Class A Common Stock (NQ:TEM)

67.24 -5.45 (-7.50%)
Streaming Delayed Price Updated: 1:26 PM EDT, Aug 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,088,062
Open 70.08
Bid (Size) 67.20 (200)
Ask (Size) 67.34 (100)
Prev. Close 72.69
Today's Range 66.38 - 72.02
52wk Range 40.77 - 104.32
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs
From Tempus AI, Inc.
Via Business Wire
News headline image
Why Tempus AI Skyrocketed This Week ↗
Tempus AI's latest acquisition is looking like a great move. 
Via The Motley Fool
Topics Artificial Intelligence Stocks

Performance

YTD
+7.8%
+7.8%
1 Month
+57.5%
+57.5%
3 Month
+44.1%
+44.1%
6 Month
+17.4%
+17.4%
1 Year
-11.4%
-11.4%

More News

Read More
News headline image
A Tempus AI Director Sold Stock Four Days Before a 24% Rally. Here's What to Know ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
Tempus AI (NASDAQ:TEM) Delivers Mixed Q2 Results with EPS Beat, Stock Slips in After-Hours Trading ↗
Via Chartmill
Topics Artificial Intelligence
News headline image
Is Tempus AI Stock a Buy After Its 75% Rally? Here's What to Know as the Firm's Legal Chief Files a Trade ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI's Accounting Chief Just Reported an Insider Transaction. Here's What Long-Term Investors Should Know ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
What to Know About the CFO of Tempus AI's Latest Insider Transaction Filing ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI's Diagnostics Chief Filed Stock Sales Spanning a Volatile Week. Here's What Happened ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI's Data Chief Just Filed a Form 4. His Segment Grew 28% Last Quarter. ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus AI's CEO Sold $6.6 Million in Stock the Day Before a Huge Rally. Here's What to Know ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
AI Found an Influenza Target That Survives Viral Mutation
From Equity Insider
Via GlobeNewswire
News headline image
Why Is Tempus AI Stock Surging on Friday? ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus AI Q2 Earnings Call Highlights ↗
Via MarketBeat
Topics Artificial Intelligence Earnings
News headline image
Tempus AI Stock Slides Friday: What's Driving the Post-Earnings Reset? ↗
Via Benzinga
Topics Artificial Intelligence
News headline image
Is Tempus AI Stock a Buy After Its CEO Sold 250,000 Shares? ↗
Via The Motley Fool
Topics Artificial Intelligence Regulatory Compliance
News headline image
Tempus Reports Second Quarter 2026 Results
From Tempus AI, Inc.
Via Business Wire
News headline image
3 Powerful AI Stocks Poised for the Next Massive Shift ↗
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine
From Tempus AI, Inc
Via Business Wire
News headline image
Tempus AI Bets on MRD Testing Growth With Personalis Acquisition ↗
Via MarketBeat
Topics Artificial Intelligence
News headline image
Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service
From Tempus
Via Business Wire
News headline image
Tempus to Report Second Quarter 2026 Financial Results on July 30
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers
From Tempus AI, Inc.
Via Business Wire
News headline image
Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm
From Tempus AI, Inc.
Via Business Wire
News headline image
Genetics in Medicine Open Study Demonstrates How Ambry Genetics’ ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing
From Ambry Genetics
Via Business Wire

Frequently Asked Questions

Is Tempus AI, Inc. - Class A Common Stock publicly traded?
Yes, Tempus AI, Inc. - Class A Common Stock is publicly traded.
What exchange does Tempus AI, Inc. - Class A Common Stock trade on?
Tempus AI, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tempus AI, Inc. - Class A Common Stock?
The ticker symbol for Tempus AI, Inc. - Class A Common Stock is TEM on the Nasdaq Stock Market
What is the current price of Tempus AI, Inc. - Class A Common Stock?
The current price of Tempus AI, Inc. - Class A Common Stock is 67.24
When was Tempus AI, Inc. - Class A Common Stock last traded?
The last trade of Tempus AI, Inc. - Class A Common Stock was at 08/24/26 01:26 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.